These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30194864)

  • 1. The role of quality-of-life instruments in predicting voice therapy dropout.
    Kavookjian H; Holcomb A; Garnett JD; Kraft S
    Laryngoscope; 2018 Dec; 128(12):2832-2837. PubMed ID: 30194864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence.
    Ebersole B; Soni RS; Moran K; Lango M; Devarajan K; Jamal N
    J Voice; 2018 May; 32(3):325-331. PubMed ID: 28709763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of voice therapy dropout.
    Hapner E; Portone-Maira C; Johns MM
    J Voice; 2009 May; 23(3):337-40. PubMed ID: 18674882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining voice therapy and physical therapy: A novel approach to treating muscle tension dysphonia.
    Craig J; Tomlinson C; Stevens K; Kotagal K; Fornadley J; Jacobson B; Garrett CG; Francis DO
    J Commun Disord; 2015; 58():169-78. PubMed ID: 26012419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the Voice Handicap Index-10 (VHI-10) and Voice-Related Quality of Life (V-RQOL) in patients with dysphonia.
    Romak JJ; Orbelo DM; Maragos NE; Ekbom DC
    J Voice; 2014 Mar; 28(2):237-40. PubMed ID: 24321582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a short version of the Spanish pediatric voice handicap index (P-VHI-10).
    Sanz L; Bau P; Arribas I; Rivera T
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():113-6. PubMed ID: 27497397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery.
    Hakkesteegt MM; Brocaar MP; Wieringa MH
    J Voice; 2010 Mar; 24(2):199-205. PubMed ID: 19185461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of voice therapy from patients diagnosed with primary muscle tension dysphonia and benign mid-membranous vocal fold lesions.
    Ziegler A; Dastolfo C; Hersan R; Rosen CA; Gartner-Schmidt J
    J Voice; 2014 Nov; 28(6):742-52. PubMed ID: 24841669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation and validation of Spanish version of the pediatric Voice Handicap Index (P-VHI).
    Sanz L; Bau P; Arribas I; Rivera T
    Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1439-43. PubMed ID: 26143124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and Cutoff Values of Self-Assessment Instruments on the Impact of a Voice Problem.
    Behlau M; Madazio G; Moreti F; Oliveira G; Dos Santos Lde M; Paulinelli BR; Couto Junior Ede B
    J Voice; 2016 Jul; 30(4):506.e9-506.e18. PubMed ID: 26168902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VHI-10 and SVHI-10 Differences in Singers' Self-perception of Dysphonia Severity.
    Renk E; Sulica L; Grossman C; Georges J; Murry T
    J Voice; 2017 May; 31(3):383.e1-383.e4. PubMed ID: 27666652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voice and Stroboscopic Characteristics in Transgender Patients Seeking Gender-Affirming Voice Care.
    Young VN; Yousef A; Zhao NW; Schneider SL
    Laryngoscope; 2021 May; 131(5):1071-1077. PubMed ID: 32750170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
    Morzaria S; Damrose EJ
    J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of laryngologist and speech pathologist coassessment on outcomes and billing revenue.
    Litts JK; Gartner-Schmidt JL; Clary MS; Gillespie AI
    Laryngoscope; 2015 Sep; 125(9):2139-42. PubMed ID: 26013916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Voice Problem Impact Scales (VPIS).
    Castro ME; Sund LT; Hoffman MR; Hapner ER
    J Voice; 2024 May; 38(3):666-673. PubMed ID: 34933795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analysis of the Effects of Voice Therapy on Patients With Early Vocal Fold Polyps.
    Zhuge P; You H; Wang H; Zhang Y; Du H
    J Voice; 2016 Nov; 30(6):698-704. PubMed ID: 26403648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of voice therapy on vocal fold polyp treatment.
    Sahin M; Gode S; Dogan M; Kirazli T; Ogut F
    Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1533-1540. PubMed ID: 29626250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and Validation of the Voice Handicap Index (VHI)-30 into Serbian.
    Sotirović J; Grgurević A; Mumović G; Grgurević U; Pavićević L; Perić A; Erdoglija M; Milojević M
    J Voice; 2016 Nov; 30(6):758.e1-758.e6. PubMed ID: 26452617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of VHI-30 to Acoustic Measurements Across Three Common Voice Disorders.
    Dehqan A; Yadegari F; Scherer RC; Dabirmoghadam P
    J Voice; 2017 Jan; 31(1):34-40. PubMed ID: 27085912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice Self-assessment Protocols: Different Trends Among Organic and Behavioral Dysphonias.
    Behlau M; Zambon F; Moreti F; Oliveira G; de Barros Couto E
    J Voice; 2017 Jan; 31(1):112.e13-112.e27. PubMed ID: 27210475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.